---
title: "SHANGHAI KAIBAO: Obtained drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225547915.md"
description: "SHANGHAI KAIBAO recently obtained the \"Drug Registration Certificate\" for its consistent decoction granules issued by the National Medical Products Administration. This drug is a prescription medication primarily used for nourishing yin and soothing the liver, suitable for symptoms such as liver yin deficiency. Obtaining the registration certificate will enhance the market competitiveness of the company's products and promote the transformation of ancient classic prescriptions into new drugs and their application in modern clinical settings"
datetime: "2025-01-20T11:35:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225547915.md)
  - [en](https://longbridge.com/en/news/225547915.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225547915.md)
generator: "portal-rs"
---

# SHANGHAI KAIBAO: Obtained drug registration certificate

Shanghai Kaibao announced that the company recently received the "Drug Registration Certificate" for the Yiguanjian Granules issued by the National Medical Products Administration. Yiguanjian Granules are prescription drugs, with a specification of 7.77g equivalent to medicinal slices per bag, 8g per bag, and 20 bags per box. The drug has a shelf life of 24 months. The main functions and indications of this drug are to nourish yin and soothe the liver, used for liver yin deficiency and blood dryness with qi stagnation, symptoms include chest and rib pain, sour regurgitation, bitter vomiting, dry throat and mouth, red tongue with little moisture, and thin wiry pulse. It is also used to treat hernias and masses. Obtaining the drug registration certificate will help enhance the market competitiveness of the company's products and promote the transformation of ancient classic prescriptions into new drugs and their widespread application in modern clinical practice

### Related Stocks

- [300039.CN](https://longbridge.com/en/quote/300039.CN.md)
- [002728.CN](https://longbridge.com/en/quote/002728.CN.md)
- [600420.CN](https://longbridge.com/en/quote/600420.CN.md)
- [600056.CN](https://longbridge.com/en/quote/600056.CN.md)
- [003020.CN](https://longbridge.com/en/quote/003020.CN.md)
- [002826.CN](https://longbridge.com/en/quote/002826.CN.md)
- [301517.CN](https://longbridge.com/en/quote/301517.CN.md)
- [000999.CN](https://longbridge.com/en/quote/000999.CN.md)

## Related News & Research

- [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md)
- [Kuwait’s KOTC tenders design consultancy for Fahaheel maritime agency project](https://longbridge.com/en/news/296795425.md)
- [Apollo Atomics wants to make nuclear power cheaper by shrinking an overlooked part](https://longbridge.com/en/news/296502139.md)
- [03:15 ETScania to showcase its broad marine offering at SMM 2026](https://longbridge.com/en/news/296749344.md)
- [Eurocastle Discloses Director Share Purchase Under EU Market Rules](https://longbridge.com/en/news/296479354.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**